SINOVAC BIOTECH LTD (SVA) Operating cash flow 2016–2025
SINOVAC BIOTECH LTD (SVA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$512.2MFY2025 · since FY2016: -$13.9M → -$512.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$512.2M | -800.3% |
| FY2024 | -$56.9M | -141.0% |
| FY2023 | $138.6M | +117.4% |
| FY2022 | -$798.1M | -105.2% |
| FY2021 | $15.3B | +3096.7% |
| FY2020 | $479.3M | +1126.7% |
| FY2019 | $39.1M | +391.9% |
| FY2018 | $7.9M | -86.7% |
| FY2017 | $59.8M | +529.8% |
| FY2016 | -$13.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice